XtalPi and Fangda Carbon Deploy Predictive AI to Optimize Cost and Material Efficiency in Graphite Electrode Manufacturing
The jointly developed AI model has passed comprehensive acceptance testing and is now operating within Fangda Carbon's production workflow. By forecasting performance and screening formulations before physical trials, the system meets cost...
From Product Photos to Campaign Content: MakeShot on AI Video Efficiency for Small Teams
Longer video generation and richer reference inputs give small businesses new ways to develop marketing content, with savings determined by the work required to reach a usable result. SINGAPORE, Sept. 24, 2026 /PRNewswire/ -- MakeShot sees the...
The Trust Test: Why Americans Buy Tool Brands They've Never Heard Of
A new VEVOR survey finds 59% of surveyed DIY tool buyers bought a tool from a brand they had never used in the past year — and when deciding whether to trust one, nearly 9 in 10 rely most on sources other than the brand itself. Fewer than 1 in 10...
Security and Data-Residency Reviews Push Enterprise AI Buyers Toward Self-Hosted Platforms, and FastGPT Publishes Its Terms
Open-source platform details private-deployment tiers, four support levels with stated first-response targets, and production results at a financial data provider, an auto-parts maker and a road-and-bridge group HANGZHOU, China, Aug. 14, 2026...
72 patient multi-indication trial approved to fast track TRP-8803 commercialisation
Human Research Ethics Committee (HREC) approval secured for world-first phase 1b/2a 8-indication basket study across in 72-patients of TRP-8803 Study will evaluate TRP-8803 (IV-infused psilocin) across eight major disorders with high unmet treatment...
Amcor partners with Kelpi to advance next-generation barrier materials for fiber packaging
ZURICH, June 29, 2026 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, today announced a collaboration with U.K.-based startup Kelpi to explore next-generation coating...
Doctors at Omotesando Helene Clinic Publish New Study on Long-Term Safety Surveillance Following High-Dose Intravenous MSC Administration
Continuing clinical data analysis and academic publication in regenerative medicine and ATMP as the Tokyo clinical hub within Helene Bio Group TOKYO, May 29, 2026 /PRNewswire/ -- Medical Corporation HELENE Omotesando Helene Clinic, located in...
NATURE'S MIRACLE HOLDING INC. ANNOUNCES STRATEGIC MOU WITH DROMNI INTELLIGENCE TO DEVELOP AI-POWERED AUTONOMOUS ROBOTICS SOLUTIONS FOR U.S. AGRICULTURE, ENERGY AND DATA CENTER MARKETS
Partnership Focused on UGV Deployment, Smart Infrastructure Automation and AI-Driven Robotics Commercialization in the United States ONTARIO, Calif., May 18, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle" or the "Company"), a...
PMET Launches Relationship with Koch Technology Solutions to Advance Value-Added Caesium Chemicals from Shaakichiuwaanaan
MONTREAL, April 16, 2026 /PRNewswire/ -- April 16, 2026 – Sydney, Australia Koch Technology Solutions, part of Koch Inc., to evaluate advanced processing pathways for PMET's globally significant caesium resource Highlights Strategic caesium testwork...
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of the Prostate...